Plasma total homocysteine in the active stage of ulcerative colitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 4, 2006, Pages 739-743

  Drzewoski, Józef ^a   Ga̧siorowska, Anita ^a   Małecka Panas, Ewa ^a   Bald, Edward ^b   Czupryniak, Leszek ^a,c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF LODZ   (Poland)

^c N Barlicki University Hospital No 1 of Medical University of Lodz   (Poland)

Author keywords

Folates; Homocysteine; Thromboembolism; Ulcerative colitis

Indexed keywords

CYANOCOBALAMIN; D DIMER; FIBRINOGEN; FOLIC ACID; HOMOCYSTEINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; ULCERATIVE COLITIS; VITAMIN BLOOD LEVEL;

EID: 33645873892     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04255.x     Document Type: Article

References (42)

1. Talbot RW Heppell J Dozois RR Beart RW Vascular complications of inflammatory bowel disease Mayo ClinProc 1986 61 140 5
2. Lee JCL Spittel JA Sauer WG Owen CA Thompson JH Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors Gastroenterology 1968 54 76 85
3. Lam A Borda IT Inwood MI Thomson S Coagulation studies in ulcerative colitis and Crohn's disease Gastroenterology 1975 68 245 51
4. Novacek G Vogelsang H Genser D et al. Changes in blood rheology caused by Crohn's disease EurJGastroenterolHepatol 1996 8 1089 93
5. Gasche C Complications of inflammatory bowel disease Hepatogastroenterology 2000 47 49 56
6. Collins CE Cahill MR Newland AC Rampton DS Platelets circulate in an activated state in inflammatory bowel disease Gastroenterology 1994 106 840 5
7. de Jong E Porte RJ Knot EA Verheijen JH Dees J Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces Gut 1989 30 188 94
8. Liebman HA Kashani N Sutherland D et al. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease Gastroenterology 1998 115 830 4
9. Chamoured P Grunebaum L Wiesel ML et al. Prevalence and significance of anticardiolipin antibodies in Crohn's disease DigDisSci 1994 39 1501 4
10. Koutroubakis I Malliaraki N Vardas E Ganotakis E Margioris A Kouroumalis E Increased levels of lipoprotein (a) in Crohn's disease; a relation to thrombosis? Gut 2000 47 Suppl. III A233
11. Van Deventer SJ Tumour necrosis factor and Crohn's disease Gut 1997 40 443 8
12. Boushey CJ Beresford SAA Omenn GS Motulsky AG A quantitative assessment of plasma homocysteine as a risk factor for vascular disease JAMA 1995 274 1049 57
13. Boers GHJ Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance ThrombHaemost 1997 78 520 2
14. Ray JG Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease ArchInternMed 1998 158 2101 6
15. Selhub J Jacques PF Wilson PWF Rush D Rosenberg IH Vitamin status and intake as primary determinants of homocysteinemia in an elderly population JAMA 1993 270 2693 8
16. Pietrzik K Bronstrup A Causes and consequences of hyperhomocysteinemia IntJVitamNutrRes 1997 67 389 95
17. Harker LA Ross R Slichter SJ Scott CR Homocysteine induced arteriosclerosis: the role of endothelial injury and platelet response in its genesis JClinInvest 1976 58 731 41
18. Stamler JS Osborne JA Jaraki O et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen JClinInvest 1993 91 303 18
19. Di Minno G Davi G Margaglione M et al. Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol sensitivity mechanism JClinInvest 1993 92 1400 6
20. Lentz SR Mechanisms of thrombosis in hyperhomocysteinemia CurrOpinHematol 1998 5 343 9
21. Kang SS Wong PW Malinow MR Hyperhomocysteinemia as a risk factor for occlusive vascular disease AnnuRevNutr 1992 12 279 98
22. Stampfer M Malinow R Wilett WC et al. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians JAMA 1992 268 877 81
23. Giles WH Croft JB Greenlund KJ Ford ES Kittner SJ Association between total homocysteine concentration and the likelihood for a history of acute myocardial infarction by race and ethnicity: results from the Third National Health and Nutrition Examination Survey AmHeart J 2000 139 446 53
24. Giles WH Croft JB Greenlund KJ Ford ES Kittner SJ Total homocysteine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994 Stroke 1998 29 2473 7
25. Hoogeven EK Kostense PJ Beks PJ et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus. A population-based study ArteriosclerThrombVascBiol 1998 18 133 8
26. Drzewoski J Czupryniak L Chwatko G Bald E Hyperhomocysteinemia in poorly controlled type 2 diabetes patients Diabetes NutrMetab 2000 13 319 24
27. Gonera RK Timmerhuis TP Leyten AC van der Heul C Two thrombotic complications in a patient with active ulcerative colitis NethJMed 1997 50 88 91
28. Cattaneo M Vecchi M Zighetti ML et al. High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? ThrombHaemost 1998 80 542 5
29. Oldenburg B Fijnheer R van der Griend R vanBerge-Henegouwen GP Koningsberger JC Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? AmJGastroenterol 2000 95 2825 30
30. Koutroubakis I Dilaveraki E Vlachonikolis IG et al. Hyperhomocysteinemia in Greek patients with inflammatory bowel disease DigDisSci 2000 45 2347 51
31. Schroeder KW Tremaine WJ Ilstrup DM Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study NEnglJMed 1987 317 1625 9
32. Chwatko G Bald E Determination of different species of homocysteine in human plasma by high-performance liquid chromatography with ultraviolet detection JChromatogr A 2002 949 141 51
33. Dinca M Burlina A Rizzotti P De Pra M Martin A Elevated homocysteine in inflammatory bowel disease (IBD) Gut 1999 45 Suppl. V A124
34. Danese S Papa A Perschilli S et al. High homocysteine levels in inflammatory bowel disease Gut 2000 47 Suppl. III A231
35. Chowers Y Sela BA Holland R Fidder H Simoni FB Bar-Meir S Increased levels of homocysteine in patients with Crohn's disease are related to folate levels AmJGastroenterol 2000 95 3498 502
36. Novacek G Miehsler W Woginger S et al. Thromboembolism in inflammatory bowel disease: preliminary results of a case-control study Gut 1999 45 Suppl. V A196
37. Abbati G Ventura P Panini R Fornaciari G Salvioli G Grandi M Hyperhomocysteinemia of IBD patients is not dependent on only impaired vitamin (B6, B12 and folic acid) status Gut 2000 47 Suppl. III A239
38. Fredholm L Brandslund I Dahler-Eriksen B Pedersen D Munkholm P Hey H Is the activation of coagulation primary or secondary to the inflammation reaction in inflammatory bowel disease (IBD)? Gut 1999 45 Suppl. V A122
39. Welch GN Loscalzo J Homocysteine and atherothrombosis NEnglJMed 1998 338 1042 50
40. Chiarantini E Valanzano R Liotta AA et al. Hemostatic abnormalities in inflammatory bowel disease Thromb Res 1996 82 137 46
41. Larsen TB Nielsen JN Fredholm L et al. Platelets and anticoagulant capacity in patients with inflammatory bowel disease PathophysiolHaemostThromb 2002 32 92 6
42. Xu G Tian KL Liu GP Zhong XJ Tang SL Sun YP Clinical significance of plasma d -dimer and von Willebrand factor levels in patients with ulcer colitis World JGastroenterol 2002 8 575 6